Cooper C. Collins insider trades: TherapeuticsMD (TXMD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Cooper reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 22, 2024 | TXMD | ↑ Buy | 4,094 | $1.73 | $7K | Direct | Aug 26, 2024 (4d) |
| Aug 21, 2024 | TXMD | ↑ Buy | 1,200 | $1.70 | $2K | Direct | Aug 23, 2024 (2d) |
| Nov 18, 2021 | TXMD | ↑ Buy | 1,000,000 | $0.58 | $579K | Direct | Nov 22, 2021 (4d) |
| Aug 18, 2021 | TXMD | ↑ Buy | 1,000,000 | $0.72 | $725K | Direct | Aug 19, 2021 (1d) |
| Jun 9, 2020 | TXMD | ↑ Buy | 74,000 | $1.45 | $107K | Direct | Jun 10, 2020 (1d) |
| May 13, 2019 | TXMD | ↑ Buy | 30,000 | $3.33 | $100K | Direct | May 15, 2019 (2d) |
| Mar 11, 2016 | TXMD | ↑ Buy | 16,000 | $6.23 | $100K | Direct | Mar 14, 2016 (3d) |
| Jun 5, 2014 | TXMD | ↑ Buy | 20,000 | $3.84 | $77K | Direct | Jun 9, 2014 (4d) |
| Apr 2, 2014 | PTX | ↓ Sell | 90,000 | $5.26 | $473K | Direct | Apr 2, 2014 (0d) |
| Mar 4, 2014 | PTX | ↓ Sell | 3,590,000 | $3.40 | $12.2M | Direct | Mar 5, 2014 (1d) |
| Feb 5, 2014 | PTX | ↓ Sell | 90,000 | $2.22 | $200K | Direct | Feb 5, 2014 (0d) |
| Jan 7, 2014 | PTX | ↓ Sell | 27,962 | $2.20 | $62K | Direct | Jan 8, 2014 (1d) |
| Jan 6, 2014 | PTX | ↓ Sell | 62,038 | $2.35 | $146K | Direct | Jan 6, 2014 (0d) |
| Dec 6, 2013 | PTX | ↓ Sell | 37,452 | $2.31 | $87K | Direct | Dec 10, 2013 (4d) |
| Dec 4, 2013 | PTX | ↓ Sell | 52,548 | $2.44 | $128K | Direct | Dec 4, 2013 (0d) |
| Nov 5, 2013 | PTX | ↓ Sell | 90,000 | $2.01 | $181K | Direct | Nov 5, 2013 (0d) |
| Oct 8, 2013 | PTX | ↓ Sell | 23,364 | $2.47 | $58K | Direct | Oct 8, 2013 (0d) |
| Oct 3, 2013 | PTX | ↓ Sell | 66,636 | $2.55 | $170K | Direct | Oct 3, 2013 (0d) |
| Jun 14, 2013 | TXMD | ↓ Sell | 2,631,579 | $1.75 | $4.6M | Permix Therapeutics Holdings, Inc. | Jun 17, 2013 (3d) |
| Jul 21, 2011 | PTX | ↓ Sell | 498,429 | $7.00 | $3.5M | Direct | Jul 25, 2011 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Cooper C. Collins's insider trades
Cooper C. Collins is an insider at TherapeuticsMD (TXMD). Since Jul 21, 2011, Cooper has reported 8 open-market purchases worth $1.7M and 12 sales worth $21.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (14 filings), option exercises (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TXMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.